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Stem cellgenesis, including hepatoblast migration and proliferation in the septum
transversum, requires the interaction of hepatic epithelium with the embryonic sinusoidal wall. No factors
that mediate this interaction have yet been identiﬁed. As the β-catenin pathway is active in hepatoblast
proliferation, then Wnt ligands might activate the canonical Wnt pathway during liver development. Here,
we investigated the role of Wnts in mediating epithelial vessel interactions in the developing chick liver. We
found that Wnt9a was speciﬁcally expressed in both endothelial and stellate cells of the embryonic
sinusoidal wall. Induced overexpression of Wnt9a resulted in hepatomegaly with hyperplasia of the
hepatocellular cords, and in hyperproliferation of hepatocytes. Knockdown of Wnt9a caused a reduction in
liver size, with hypoplasia of hepatocellular cord branching, and hypoproliferation of hepatoblasts, and also
inhibited glycogen accumulation at later developmental stages. Wnt9a promoted in vivo stabilization of β-
catenin through binding with Frizzled 4, 7, and 9, and activated TOPﬂash reporter expression in vitro via
Frizzled 7 and 9. Our results demonstrate that Wnt9a from the embryonic sinusoidal wall is required for the
proper morphogenesis of chick hepatocellular cords, proliferation of hepatoblasts/hepatocytes, and glycogen
accumulation in hepatocytes. Wnt9a signaling appears to be mediated by an Fzd7/9-β-catenin pathway.
© 2008 Elsevier Inc. All rights reserved.IntroductionThe liver is the center of metabolism for carbohydrates, fats, and
proteins in vertebrates. To perform these metabolic functions
effectively, the liver possesses a microstructure composed of hepato-
cellular cords, single cell thick epithelial sheets of hepatocytes. The
hepatocellular cords are lined by a wall of sinusoids (capillaries
characteristic of liver), that is mainly composed of endothelial and
stellate cells (DeRuiter et al., 1993; Gouysse et al., 2002). From the
portal–central vein, portal blood is transported to the hepatocytes of
the hepatocellular cords via the sinusoids (Wisse et al., 1985). The
blood plasma can pass into the subendothelial space of Disse through
the fenestrated endothelium of the sinusoids and substances from the
blood can then diffuse into the hepatocytes where they are
metabolized. Finally, the portal blood plasma containing the metabo-ouchi).
l rights reserved.lites drains into the central vein via the sinusoids (Cooper, 1997; Havel
and Hamilton, 2004; Mahley and Ji, 1999). Thus, the hepatic sinusoids
are essential for the metabolic function of the liver.
In the liver development, hepatic epithelium and the blood vessels
appear to be mutually interdependent. In the interaction between
hepatic epithelium and blood vessels, especially, the blood vessels or
their precursors have important roles for liver development in
mammalian embryos. At E8.5 of mouse embryo development, hepatic
endoderm, induced from the foregut by ﬁbroblast growth factors
(FGFs) from the cardiac mesoderm, invaginates into the adjacent
septum transversum mesenchyme (STM) to form a liver bud
composed of a multi-layered epithelium (Jung et al., 1999; Rossi et
al., 2001). Next, at E9.5, hepatoblasts from the liver bud migrate into
the septum transversumwhere they proliferate to form the embryonic
hepatocellular cords. Formation of the hepatocellular cords is
accompanied by formation of the embryonic sinusoids that line the
cords (Hentsch et al., 1996; Matsumoto et al., 2001; Sosa-Pineda et al.,
2000; Zhao and Duncan, 2005). The intimate relationship between the
embryonic hepatic epithelium and the embryonic sinusoids suggests
Table 1
PCR oligonucleotides
Gene Forward primer (5′–3′) Reverse primer (5′–3′)
Frizzled-1 CTTCATGAGTCGCAACTTCG TCCACCAGGTAGGTGAGGAC
Frizzled-2 TCAACGAGGACGAGATCC GCGTGTAGAACTTCCTCC
Frizzled-3 GCAGACAGCAGCATTAGC AACCAACAGTGGCACGAG
Frizzled-4 AACAGGAACAGAGGCAGG AACCAGAACCTGGATGCG
Frizzled-5 AGCTATGCGCAGTACTTCC CAAGACTCGAGAGTTTTGCC
Frizzled-6 TCGATCAGTGTGCACCAC TTGTTGTGCCACCTGTGC
Frizzled-7 CCTCAACCAGACCATCC CGTGCTTCATGATGGTGC
Frizzled-8 GGTGTGATGACTGGACGTC GCATGAAGACGGCGTAGTC
Frizzled-9 GACAACCCCGAGAAGTTCC CCATCCAGACGAAGGCAAAGTCC
Frizzled-10 TCAGTGTGAGCAGGCGAG TCAGCTCATCTCCAGCCAC
Tcf-1 TCAAGTCCTCGTTGGTG AGGATCTGGTTGATGG
Tcf-3 ATGTCCAGCCTGATGTCCAG GTCTGTGGTGCACAGC
Tcf-4 GGATGGTTAGTACCAC CTTCCATCTGAAGAGG
Β-catenin GAAGGCCTTCTAGGAACTC GCAACTCTACAGGCCAATC
Wnt9aa ACGAAGCCCTGACCATCCT CGTCTCCTTGAAACCTCTC
Gapdha ACG CCATCACTATCTTCCAG CAGCCT TCACTACCCTCTTG
Pepcka TGAGTCGACAGATTCTCC ACATCCAACCGATGAAG
G6pasea TGAGACCTTCCAGCACATCC TCTGTGCCTTCTCCAGTGTC
Gysa ATCATGCAACCAGCTGACTC GGAGCACATGGTTCCATCTC
Glycogen
phosphorylasea
GCACCTGGACCATATTGCGT TTGGCCACTCCGTTGACAG
Envb AAACGAAGCACCTCACACC AAGGCAGGCACACTACTAG
Flk-1b CTCTCCCAACTTCACCTGC CACTTGTCTGGTTGGATGC
Primer sequences used for PCR ampliﬁcation.
a Used for qReal-time and semi-quantitative RT-PCR.
b Used for semi-quantitative RT-PCR.
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Recently, the VEGFR2 null mouse embryo, which lacks endothelial
cells around the liver bud, was reported to exhibit complete arrest of
migration of hepatoblasts from the liver bud and of hepatocellular
cord formation in the septum transversum (Matsumoto et al., 2001).
These data strongly suggest that some factor secreted from the
embryonic sinusoidal wall, or its precursors, controls the migration
and proliferation of hepatoblasts.
In the chick embryo, blood vessels are also crucial for liver bud
morphogenesis during liver development. The initial phase of
embryonic hepatic histogenesis involves a species-speciﬁc morpho-
genetic process at the ductus venosus (Yokouchi, 2005). Subsequent
development involves morphogenetic processes that show conserva-
tion across species. During the early developmental processes
(Hamburger–Hamilton stages (HH)14–17, E2–2.5), the liver buds
(anterior hepatic diverticulum and posterior hepatic diverticulum on
the dorsal and ventral sides, respectively, of the ductus venosus, a vein
in the septum transversum unique to the avian embryo) elongate
along the ductus venosus in both anterior and lateral directions to
envelop the ductus venosus (Le Douarin, 1975; Romanoff, 1960;
Yokouchi, 2005). This process is regulated by Neurturin, a chemoat-
tractant expressed in the ductus venosus (Tatsumi et al., 2007). At
subsequent stages of development (HH17+-, E2.5-), hepatoblasts from
the liver buds migrate in a radial direction in the STM to form
embryonic hepatocellular cords, with the accompanying formation of
embryonic sinusoids. This conserved developmental process suggests
that the embryonic sinusoids also play an important role in
hepatocellular cord formation in the developing chick liver. To date,
however, the factor(s) derived from the embryonic sinusoidal wall
that promotes hepatocellular cord formation has not been identiﬁed.
Wnts are secreted signaling molecules that play various roles in
cellular proliferation, differentiation, patterning and cell polarity in
ligand- or context-dependent manners during development. Wnt
signaling is mediated by canonical or non-canonical pathways
(Gordon and Nusse, 2006; Logan and Nusse, 2004). In the canonical
pathway, β-catenin plays a crucial role in signaling. Wnt binds to
receptors on Frizzled (Fzd) proteins to inactivate the β-catenin
degradation complex (Axin/APC/GSK3-β) through Dishevelled (Dvl).
In this situation, cytoplasmic β-catenin that is not phosphorylated
dissociates from the complex (stabilized), binds with Tcf/Lef families,
translocates into the nucleus, and ﬁnally activates transcription ofWnt
target genes.
Recently, β-catenin was reported to be important for hepatoblast
proliferation in mouse and chick embryos. In E10–14 mouse livers, β-
catenin is stabilized in the hepatic cells and localized in the nuclei of
hepatoblasts (Micsenyi et al., 2004). Morpholino-induced knockdown
of β-catenin in cultured mouse liver slices inhibited hepatoblast
proliferation and increased apoptosis (Sodhi et al., 2005). In chick
embryos, induced overexpression of the constitutively active form of
β-catenin caused hepatomegaly and hyperproliferation of hepato-
blasts (Suksaweang et al., 2004). Moreover, induced expression of
Dkk-1, a strong Wnt antagonist, caused liver hypoplasia and
hypoproliferation of hepatoblasts (Suksaweang et al., 2004). These
observations suggest the existence of a Wnt ligand that activates the
canonical Wnt pathway in the developing liver and is involved in
hepatoblast proliferation.
In our previous study, we searched for Wnt ligand(s) that mediate
epithelial–mesenchymal interactions in the developing chick liver
(Yokouchi, 2005) and found that Wnt9a was expressed in the hepatic
vein of the HH17 (E2.5) chick liver.
Here, we investigated the expression pattern of Wnt9a in the
developing chick liver, and performed functional analyses using gain-
of-function and loss-of-function strategies to elucidate the signal
transduction mechanism. Our data demonstrate that Wnt9a emanat-
ing from the embryonic sinusoidal wall is required for proper
morphogenesis, proliferation, and glycogen accumulation of thechick hepatic epithelium and that Wnt9a signaling appears to be
mediated by the Fzd7/9-β-catenin pathway.
Materials and methods
Embryos
SPF chick embryos were obtained by incubation of fertilized White Leghorn eggs
(Takeuchi hatchery, Nara, Japan) and were staged according to Hamburger and
Hamilton (1951) and by day of incubation (embryonic day, E).
In situ hybridization
Embryos were ﬁxed in 4% paraformaldehyde/PBS and processed for cryosectioning
or parafﬁn wax sectioning as described previously (Wilkinson, 1993) and sectioned at
10 μm, except for the sections in Figs. 5G, H (5 μm). Parafﬁn wax embedded embryos
were sectioned at 8 μm. Single- and double-colored in situ hybridizations were
performed as described previously (Wilkinson, 1993) with minor modiﬁcations (see
Supplementary methods). The probes for hhex, Albumin and Env were prepared as
described previously (Yanai et al., 2005) (Takeuchi et al., 2003). The Wnt9a probe was
transcribed from ChEST530d5 (MRC Geneservice). Other probes were transcribed from
the appropriate templates by RT-PCR using the primers listed in Table 1.
Knockdown of gene expression
Details of the following protocols are given in the Supplementary methods:
designing templates for small hairpin RNAs (shRNAs) against Wnt9a; construction of an
shRNA expressing vector in pEGFPH1 (a kind gift from Dr. Chi-chung Hui, this plasmid
transcribes EGFP mRNA under a CMV promoter and can transcribe a shRNA composed
of two complements of 19 nt sequences separated by a 4 nt spacer, under a human H1
promoter); the gene silencing assay for evaluating shRNAs; construction of the GFP-
Wnt9a expressing vector; and, construction of RCAS(BP)A carrying an H1 promoter and
shRNAs templates.
Immunoprecipitation assay and immunoblotting
For the binding assaywith Frizzled, cWnt9a-Fc and GFP-Fcwere constructed by PCR
from the full-length cDNAs ofWnt9a and GFP using the following primers and pSlax12-
Wnt9a and pEGFPN1 as templates, respectively: for Wnt9a-Fc, (5′-CGACTAGTACT-
CACTCCCGTCTTTACAGGTGTAAAC-3′, 5′-ATTACCCCTCAC TAAAGG-3′ (T3 primer
sequence of pSlaxWnt9a)); for GFP-Fc, (5′-CGACTAGTACTCACTCTTGTACAGCTCGTCCATGC-3′, 5′-
TAGTGAACCGTCAGATCCG-3′). The PCR products were inserted into the pEF–Fc vector that
encodes the Fc domain of human IgG (kind gift of Dr. Tanaka H, Kumamoto University).
cFzd1 was obtained by RT-PCR using the primers listed in Table 1. mFzd4 was a gift from
Dr. S. Nakagawa, Riken Wako. Full-length mFzd7 and hFzd9 were purchased from
Invitrogen. To produce the cysteine rich domain (CRD) at the N-terminus of Frizzled
proteins (Fzd-CRD), partial cDNAs for cFzd1-CRD (1–228), mFzd7-CRD (1–241) and
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into pcDNA3.1-His-myc (Invitrogen).
The Fzd binding study was performed as described previously (Kubo et al., 2003)
with minor modiﬁcations. Brieﬂy, COS7 cells were co-transfected with pcDNA3.1-Fzds-
CRD-myc and pEF-Wnt9a-Fc using Polyfect (Qiagen). As a control, pEF-GFP-Fc was used
instead of pEF-Wnt9a-Fc. After 48 h, the cells were incubated in 1 ml of binding buffer
(1% Triton X-100, 1% NP-40, 1 mM EDTA in PBS) for 30 min at 4 °C. The cell lysates were
incubated with 50 μl of ProteinA Sepharose-4B beads (GE Healthcare) for 30 min at 4 °C.
After washing, the immunoprecipitated complex was lyzed in SDS-PAGE sample buffer,
and analyzed byWestern blotting. Myc and Fc were detected using amousemonoclonal
antibody (1:1000, Invitrogen) and a rabbit anti-human IgG-Fc (1:10000, Jackson
Laboratory), respectively, followed by HRP-conjugated goat anti-mouse IgG (GE
Healthcare) and HRP-conjugated goat anti-rabbit IgG (GE Healthcare), respectively.
For detection of nuclear β-catenin, E2 (HH10–11) chick embryos were infected with
RCAS virus and incubated for 3 days. Nuclear lysates were prepared from livers
harvested at E4.5 (HH25) using the Subcellular Proteome Extraction kit (Calbiochem),
and analyzed byWestern blotting. β-catenin and lamin A/C were detected with a rabbit
anti-β-catenin antibody (1:2000, clone C2206, SIGMA) and a mouse anti-human lamin
A/C antibody (1:1000, #612162, BD Transduction Laboratories), respectively, followed
byHRP-conjugated goat anti-mouse IgG (GE Healthcare) and HRP-conjugated goat anti-
rabbit IgG (GE Healthcare), respectively.
Reporter analysis
Liver cell cultures were performed as described previously (Miki et al., 2008) with a
minor modiﬁcation. Brieﬂy, E6 (HH29) livers were treated with dispase I (5 mg/ml,
Roche) in DMEM (GIBCO) for 40 min at RT, and dissociated into single cells by pipetting.
Cells (5×104) were resuspended in DMEM with 10% FCS and antibiotics, plated in 24-
well plates 18 h before transfection, and transfected using FuGENEHD (Roche
Diagnostics) with a TOPﬂash luciferase reporter (Upstate Biotech, 0.33 μg/well),
RCAS-GFP, RCAS-cWnt9a (0.16 μg/well), and pRSV40 (0.005 μg/well). Cells were
incubated for an additional 24 h. Fireﬂy luciferase and Renilla luciferase activities
were measured with a luminometer using the Dual Luciferase System (Promega).
Immunohistochemistry, BrdU labeling, and TUNEL assay
Immunohistochemistry was performed as described previously (Tatsumi et al.,
2007), using the following primary antibodies: mouse anti-E-cadherin (1:300, BD
Transduction); rabbit anti-β-catenin (1:2000, C2206, Sigma); rabbit anti-DESMIN (1:20,
D8281, Sigma); rabbit anti-GFP (1:1000, #598, MBL); monoclonal anti-PCNA (1:1000,
PC10, Sigma). Detection was performed with the following secondary antibodies:
Fluorolink Cy3-labeled goat anti-mouse IgG (1:300, Amersham Biosciences); Alexa-
Fluor 488 goat anti-rabbit IgG (1:300, Molecular Probes); Fluorolink Cy3-labeled goat
anti-rabbit IgG (1:300, Amersham Biosciences) and AlexaFluor488 goat anti-mouse IgG
(1:300, Molecular Probes). Immunohistochemistry after in situ hybridization (Fig. 2) is
described in detail in the Supplementary methods. To study cell proliferation at E5
(HH27), 2–3 μl of 50 mM BrdU were injected into the allantoic vein 30 min before
ﬁxation. Mitotic cells incorporating BrdU were detected using a BrdU Labeling and
Detection kit I (Roche). Apoptosis was assessed by the TUNEL technique using an in situ
Apoptosis Detection Kit (TAKARA). After these procedures, the specimens were stained
with DAPI (Nakarai) to enable cell numbers to be counted.
Production of viral vectors and infection of embryos
RCAS(BP)A-cWnt9a was kindly provided by Dr. C. Hartmann (Hartmann and Tabin,
2001). Production of recombinant viruses was performed as described previously
(Laufer et al., 1997). Brieﬂy, RCAS(BP)A-Wnt9a, RCAS(BP)A-GFP, RCAS(BP)A-Wnt9a314,
RCAS(BP)A-Cont314, RCAS(BP)B-Wnt9a mut, RCAS(BP)A-Wnt9a556, RCAS(BP)A-Cont556,
or RCAS(A)-Wnt9aΔ288 were transfected into DF-1 cells, and the concentrated
supernatants were stored. For the overexpression study, the viral solution was injected
into the coelom of an E3 (HH20) SPF chick embryo (Takeuchi farm, Nara, Japan) to allow
the viral particle to infect the hepatic mesothelium, the origin of sinusoidal endothelial
cells and stellate cells (Perez-Pomares et al., 2004). For the loss-of-function study, viral
solutionwas injected into the presumptive hepaticmesoderm of E2 (HH10–11) embryos
(Matsushita, 1999) to enable effective infection before the onset of Wnt9a expression.
In ovo electroporation
Electroporation was performed as described (Grapin-Botton et al., 2001) with
minor modiﬁcations. Brieﬂy, a few drops of PBS were added to the top of the E2.25
(HH15–16) embryo. The DNA solution (5 mg/ml) was placed on the mesothelial surface
of the liver. The liver was sandwiched between a positive electrode (below) and a
negative electrode (above) parallel to the anterior–posterior axis. Three square-wave
current pulses (17 V, 50 ms) were applied to the embryo using a CUY21 electroporator
(Tokiwa Science, Japan). Embryos were cultured at 38 °C for 24 or 48 h.
Semi-quantitative RT-PCR assay and real-time quantitative RT-PCR assay
The semi-quantitative RT-PCR assay for expression proﬁling of livers infected
with recombinant virus was performed as described previously (Nakayama et al.,2006), using PTC-200 (BioRad). A real-time quantitative RT-PCR assay was
performed as described previously (Miki et al., 2008), using the ABI PRISM 7700
Sequence Detection System (version 1.6) with SYBR Green PCR Master Mix
(Applied Biosystems, CA, USA). The PCR conditions were as follows: denaturation
at 95 °C for 10 min, followed by 40 cycles of denaturation at 95 °C for 30 s,
annealing at 60 °C for 30 s, and extension at 72 °C for 30 s. The primers are listed
in Table 1.
Statistical analysis
Changes in liver weights were determined by weighing 5–7 livers of chick embryos
from each experimental condition (Figs. 3B and 5B, Supplementary Fig. 2C and
Supplementary Fig. 3C). For the proliferation analysis (Fig. 3M), 300–1500 cells were
counted per experimental condition in eight or nine replicates. For pair wise analyses,
Student's t-test was used. ANOVA followed by Fisher's Protected Least Signiﬁcance
Difference (PLSD) test was used for comparison of multiple groups (Fig. 5I). P values less
than 0.05 were considered to be statistically signiﬁcant. The data are expressed as
means±SE.
Results
Wnt9a is expressed in sinusoidal cells in the developing chick liver
We screened Wnt expression patterns to identify those Wnts
that are involved in epithelial–mesenchymal interactions during
liver development (Yokouchi, 2005). Wnt9a was found to be
expressed in the sinusoidal cells lining the hepatoblasts in the
developing chick liver (Fig. 1). Semi-quantitative RT-PCR showed
that Wnt9a was expressed from E4 (HH24) to E14 (HH40): expres-
sion peaked at E4 (HH24) and gradually decreased from E6 (HH29)
to E14 (HH40) (Fig. 1P).
Next, we investigated the detailed Wnt9a expression pattern at
different embryonic stages. Wnt9a expression was compared to
those of Flk-1 and hhex by in situ hybridization on adjacent liver
sections; Flk-1 and hhex are markers for endothelial cells and
hepatic epithelium, respectively (Yanai et al., 2005; Yatskievych et
al., 1999). At HH16 (E2.25), when the hepatic diverticula extend in
an anterior direction on the ductus venosus and the sinusoidal space
has already formed (Figs. 1A, C), Wnt9a could not be detected in the
developing liver (Fig. 1B). At HH17 (E2.5), when hepatoblasts
migrate from the posterior hepatic diverticulum into the STM and
intermingle with endothelial cells (Figs. 1D, G, and F), Wnt9a was
detected in the submesothelial layer and sinusoidal cells (Figs. 1E,
arrowheads in H and I). At HH25 (E4.5), when hepatocellular cords,
and sinusoidal walls rapidly proliferate to form an interdigitated
structure (Figs. 1J, M), Wnt9a and Flk-1 were expressed in sinusoidal
lining in the central region of the liver (Figs. 1K, N, and L, O). There
were a few cells expressing Wnt9a in the ductus venosus. At E6
(HH29), the scattered Wnt9a expression in the central sinusoidal
region and in the peripheral submesothelial region was maintained
(Supplementary Fig. 1). At E8 (HH34) and E10 (HH36), when
hepatocellular cord formation is continuing, the scattered sinusoidal
expression of Wnt9a was maintained but submesothelial expression
ceased except at the apex of the E8 (HH34) liver (Supplementary Fig.
1). At E14 (HH40), when hepatoblasts have differentiated into
hepatocytes and biliary epithelial cells, the scattered expression of
Wnt9a in the central sinusoidal region was maintained (Supple-
mentary Fig. 1). These suggest that Wnt9a might be involved in the
morphogenesis of the hepatic diverticulum (or liver bud) at HH17
(E2.5), proliferation of hepatoblasts, morphogenesis of hepatocellu-
lar cords during E5 (HH27) to E10 (HH36), and differentiation at E14
(HH40).
Additionally, in parallel with this, we investigated genes encoding
glycogen and glucose metabolic enzymes as potential differentiation
markers to distinguish hepatocytes from hepatoblasts. Of the four
candidate genes, glucose synthase (Gys) was speciﬁcally expressed at
E10 and E15, when glycogen accumulation is detectable, but not at E5.
Therefore, Gys is suitable for use as a hepatocyte differentiation
marker (Supplementary Fig. 5).
Fig. 1.Wnt9a expression in the developing chick liver. mRNA distributions of hhex,Wnt9a, and Flk-1 in adjacent transverse sections of chick livers at different stages. (A–C) At HH16
(E2.25), there is no evidence that Wnt9a expression has commenced. (D–F) At HH17 (E2.5),Wnt9a is expressed in the sinusoidal wall and submesothelial layer. (G–I) Enlargements of
the boxes in panels D and E. Arrowheads in panels G–I indicate hepatoblasts migrating from the posterior hepatic diverticulum, sinusoidal cells expressing Wnt9a, and
submesothelial cells expressing Wnt9a, respectively. (J–L) At HH25 (E4.5), Wnt9a is expressed in the sinusoidal wall. (M–O) Enlargements of the boxes in panels J–L. (P) Temporal
pattern of Wnt9a expression in E4 (HH24) to E14 (HH40) chick livers. The expression level peaked at E4 (HH24) and E6 (HH29). ahd, anterior hepatic diverticulum; phd, posterior
hepatic diverticulum; dv, ductus venosus; s, sinusoid; stm, septum transversum mesenchyme. Bars, 0.5 mm.
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The sinusoidal wall is composed principally of endothelial and
stellate (Ito) cells. To determine which cell types express Wnt9a, we
carried out dual detection of Wnt9a and Flk-1, an endothelial cell
marker, orWnt9a and DESMIN, a stellate cell marker, (Tsutsumi et al.,
1987; Yokoi et al., 1984), in HH25 (E4.5) livers. Wnt9a frequently co-
localized with Flk-1+ endothelial cells in sinusoidal walls across theentire liver (Figs. 2A, arrowheads in B) except for the ductus venosus
(data not shown). Similarly, double-positive cells for Wnt9a and
DESMIN were frequently detected in sinusoidal walls (Figs. 2C, D,
white arrowheads). These results indicate that Wnt9a expression is
not restricted to either the endothelial or the stellate cell lineage but is
present in both.
HH17 (E2.5) mesothelial cells in the quail liver migrate into the
submesothelial space, and contribute to both endothelial and stellate
Fig. 2. Cell types and origin of Wnt9a-positive cells in the chick liver. (A, B) Double-
colored in situ hybridization of transverse sections of HH25 (E4.5) chick livers. (A) Blue
and brown, Wnt9a and Flk-1, respectively. h, heart. (B) Enlargement of the box in panel
A. Arrowheads, Wnt9a/Flk-1 double-positive cells. (C, D) Simultaneous detection of
Wnt9amRNA and DESMIN protein on transverse sections of HH25 (E4.5) chick liver. Red
and green, Wnt9a mRNA and DESMIN, respectively. (C) Wnt9a mRNA. (D) Dual color
image of panel C. Arrowheads, Wnt9a/DESMIN double-positive cells. (E, F) Lineage
tracing to identify the origins of Wnt9a positive cells. (F) At E4.5 (HH25), mesothelial
cells (labeled here with pCAGGS-GFP) at HH15–16 (E2.25) migrate into the
submesothelial layers and are integrated into the sinusoidal wall. (E) In situ
hybridization for Wnt9a of the same section as in panel F. Arrowheads, GFP/Wnt9a
double-positive cells. Bars, 0.5 mm.
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migration coincides with the onset of Wnt9a expression (Fig. 1E), and
Wnt9a was expressed in both endothelial and stellate cells of
sinusoidal walls (Figs. 2B, D), suggesting that Wnt9a-positive cells in
the sinusoidal walls might be derived from mesothelium. To test this,
we electroplated pCAGGS-GFP into the hepaticmesothelium at HH15–
16 (E2.25), a stage prior to mesothelial cell migration, and examined
whether GFP-positive mesothelium-derived sinusoidal cells also
expressed Wnt9a. At 48 and 72 h after electroporation, GFP-positive
cells were present in the sinusoidal walls (Fig. 2F). Some GFP-positive
cells expressed Wnt9a (Figs. 2E, F, black and white arrowheads show
identical cells) indicating that Wnt9a-positive cells in sinusoidal walls
derived from mesothelium.
Wnt9a overexpression induces hepatomegaly due to hyperproliferation
of hepatic epithelium
To investigate the role of Wnt9a in the sinusoidal cells during
liver development, we overexpressed Wnt9a in the embryonic chick
liver using an RCAS retroviral vector expressing Wnt9a (RCAS(BP)A-
Wnt9a). Because E3 chick hepatic mesothelium contributes in part to
hepatic sinusoidal cells (Perez-Pomares et al., 2004), we infected
RCAS(BP)A-Wnt9a into E3 (HH20) mesothelium. Viral products are
detectable at 18 h after infection, but not 10 h (Morgan and Fekete,1996). Infection was conﬁrmed by RT-PCR and in situ hybridization
for Env, an envelope protein of the Rous sarcoma virus (Hughes et
al., 1987; Takeuchi et al., 2003). At E15 (HH41), when the liver is
composed of Gys-positive hepatocytes (Supplementary Fig. 5),
patchy infection was restricted to the sinusoidal cells with none
the hepatic epithelium (Figs. 3C, D). Wnt9a overexpression in
sinusoidal cells caused enlargement of the liver at E10 (HH36)
(data not shown) and E15 (HH41) (Fig. 3A) and resulted in a 1.4-fold
increase in the gross weight of the liver compared to the control at
E15 (HH41) (Pb0.005, Fig. 3B). Livers with overexpression of Wnt9a
showed a peripheral accumulation of blood cells (hematoma) (Fig.
3A, arrowheads) that was not observed in control (GFP over-
expressing) livers.
At the histological level, a tighter packaging of the hepatic
epithelium (hyperplasia) with the normal epithelial polarity was
often observed in peripheral regions of livers overexpressing Wnt9a
(Fig. 3F, arrowheads) compared to the control (Fig. 3E). There was
evidence for vessel stenoses as ex-vivo vascular perfusion could not
clear the observed hematomas (Fig. 3A, right). The stenoses appeared
to be caused by hepatocellular cord hyperplasia. In addition, there was
no indication of edema. These observations suggest that the enlarge-
ment of the liver and the weight increase that resulted from
overexpression of Wnt9a were the consequence of hyperplasia of
the hepatic epithelium and not edema.
To determine whether the weight increase and the hepatocel-
lular cord hyperplasia induced by Wnt9a overexpression were
caused by hyperproliferation of hepatocytes, we quantiﬁed the
mitotic index in livers after PCNA staining. At E15 (HH41), Wnt9a
overexpression induced a 1.7-fold increase in the proliferation rate
compared to the control (Figs. 3I, J, and M). These results are similar
to those recorded following β-catenin overexpression (Suksaweang
et al., 2004). Assessment of the proliferation rate using BrdU
labeling of E6 (HH29) embryos also indicated that Wnt9a over-
expression induced a 1.7-fold increase (data not shown). RCAS(BP)A-
Wnt9a did not affect expression of the early hepatic marker hhex or
the hepatocyte marker Albumin in E10 (HH36) livers (data not
shown). Overall, these data strongly suggest that Wnt9a over-
expression promoted proliferation of hepatocytes and thereby
caused hyperplasia of the hepatocellular cords and the weight
increase in affected livers.
In addition, Wnt9a overexpression induced an increase in the
mitotic index in E6 affected livers (data not shown), which are
composed of Gys-negative hepatoblasts (Supplementary Fig. 5).
Overexpression did not affect apoptosis and glycogen accumulation
in E15 affected livers (data not shown).
Sequence speciﬁc silencing of cWnt9a by a vector expressing shRNA
To analyze the role of Wnt9a in the morphogenesis of the hepatic
epithelium in the developing chick liver, we used a short hairpin
interfering RNA (shRNA) targeting cWnt9a to knock down endogen-
ous Wnt9a. Prior to performing an in vivo knockdown, we evaluated
the efﬁcacy of various shRNAs against cWnt9a using an in vitro assay
of RNA interference activity. Co-transfection of pEGFPH1-Wnt9a (the
vector containing the templates for shRNAs against cWnt9a under a
human H1 promoter) and pEGFPN-cWnt9a (1–600) (a vector
expressing GFP-tagged Wnt9a) revealed that Wnt9a314 had the
strongest activity for silencing cWnt9a RNA of the three tested
candidates (Wnt9a77, Wnt9a556, Wnt9a561; Supplementary Fig. 3A).
Cont314, which has a scrambled sequence of Wnt9a314 (Supplemen-
tary Fig. 3B, lower), was used as a negative control and did not silence
cWnt9a (Supplementary Fig. 3C, right). In a rescue experiment, we
constructed a shRNA-resistant form of Wnt9a (Wnt9a mut) that
contains six silent mutations within the Wnt9a314 recognition site
(Supplementary Fig. 3D). The construct was not silenced by Wnt9a314
(Supplementary Fig. 3E).
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and hypoproliferation of hepatoblasts
To knock down endogenous cWnt9a in vivo, E2 (HH10–11)
presumptive hepatic mesoderm (Matsushita, 1999) was infected
with either RCAS(BP)A-Wnt9a314 (RCAS(BP)A expressing Wnt9a314),
or RCAS(BP)A-Cont314 (RCAS(BP)A expressing the scrambled shRNA
to Wnt9a314) as a control (Fig. 4A). Three days after infection, the
level of cWnt9a mRNA in E5 (HH27) livers infected with RCAS(BP)A-
Wnt9a314 was reduced by 60–70% (Fig. 4B); E5 is the developmental
stage at which Wnt9a mRNA peaked in the normal liver (Fig. 1P). At
E5 (HH27), the liver is composed of Gys-negative hepatoblasts
(Supplementary Fig. 5). After infection with RCAS-Wnt9a314, the
livers appeared to display hypoplasia of hepatocellular cord branch-
ing compared to the control (Figs. 4F, G), although the hepatocellular
cords were aligned with the normal epithelial polarity. We also
found that RCAS-Wnt9a314 caused an 18% reduction in the mitotic
index of infected livers, compared to the control (Fig. 4I). To conﬁrm
that hypoplasia of hepatocellular cord branching and hypoprolifera-
tion of hepatoblasts in RCAS-Wnt9a314-infected livers were directly
caused by Wnt9a silencing, we performed a rescue experiment. Co-
infection of RCAS(BP)B-Wnt9a mut and RCAS-Wnt9a314 resulted in a
considerable rescue of the hypoplasia caused by RCAS(BP)A-
Wnt9a314 (Fig. 4H, Supplementary Fig. 4A) and restored the mitotic
index to the normal level (Fig. 4I). These results indicate that Wnt9a
is required for the normal morphogenesis of hepatocellular cords
and for maintenance of the hepatoblast proliferation rate during the
growing stages of the developing chick liver. We also performed
alternative loss-of-function analysis using the RCAS dominant-
negative Wnt9a (Wnt9aΔ288) (Person et al., 2005) to block Wnt9a
signaling and observed similar results (Supplementary Figs. 2A–F).
RCAS(BP)A-Wnt9a314 did not affect expression of hhex (a homeobox
gene required for formation of hepatic epithelium) or Prox1 (a
homeobox gene required for hepatoblasts migration) in E5 livers
(data not shown).
cWnt9a silencing induces hepatic hypoplasia at later stages
We next examined the effect of cWnt9a silencing at a later
developmental stage (E15; HH41), when the liver is composed of
Gys-positive hepatocytes (Supplementary Fig. 5), by screening the
gross phenotypes of livers infected with RCAS(BP)A-Wnt9a314. In
contrast to the gain-of-function study, RCAS(BP)A-Wnt9a314 drama-
tically decreased liver size and resulted in a 1.6-fold decrease in
gross liver weight compared to the control (Fig. 5A, B; Pb0.006). In
situ hybridization for Env or Wnt9a showed that the livers had
nearly ubiquitous infection with RCAS(BP)A-Wnt9a314 or RCAS(BP)A-
Cont314 (Figs. 5C, D) and the obvious knockdown of endogenous
Wnt9a in the former (Figs. 5E, F). H&E staining revealed that RCAS-
Wnt9a314 frequently induced hypoplasia of hepatocellular cordFig. 3.Wnt9a overexpression effects on the developing chick liver. (A) Gross anatomy of
E15 (HH41) livers infected with either RCAS(A)-GFP (left) or RCAS(A)-Wnt9a (right).
RCAS(A)-Wnt9a infection caused hepatomegaly. Arrowheads, hematomas on a liver
infected with RCAS(A)-Wnt9a. (B)Wet weights of E15 (HH41) livers infected with either
RCAS(A)-GFP (open column) or RCAS(A)-Wnt9a (ﬁlled column). RCAS(A)-Wnt9a
increased the mean weight of the infected liver (Pb0.005). N, the number of samples.
(C, D) Env distribution in liver sections after either RCAS(A)-GFP (C) or RCAS(A)-Wnt9a
infection (D). Mesenchymal cells in both treatment groups showed similar levels of
infection. (E, F) H&E stained sections of livers with either RCAS(A)-GFP (E) or RCAS(A)-
Wnt9a (F). Arrowheads, hyperplasia of the hepatocellular cords (F). (G, H) β-catenin
distribution in livers infected with either RCAS(A)-GFP (G) or RCAS(A)-Wnt9a (H).
Cytoplasmic and membranous β-catenin staining is obviously stronger in panel H than
in panel G. (I, J) PCNA distribution in livers infected with either RCAS(A)-GFP (I) or RCAS
(A)-Wnt9a (J). (K, L) DAPI staining of panels I and J, respectively. (M) Mitotic indexes of
hepatic epithelial cells from livers infectedwith either RCAS(A)-GFP (white) or RCAS(A)-
Wnt9a (black). Livers infected with RCAS(A)-Wnt9a showed an increased mitotic index
(Pb0.005). Bars, 1 mm.
Fig. 4. Construction of RCAS vector expressing shRNAs and the effect of Wnt9a silencing on E5 (HH27) chick livers. (A) Schematic of RCAS vectors carrying templates for Wnt9a314 or
Cont314. H1 (yellow arrowhead) and Term, the human H1 promoter and termination sequence, respectively. S (blue arrow) and AS (red arrow), the sense and antisense strands of the
hairpin RNA template, respectively. (B)Wnt9a silencing by RCAS expressing an shRNA againstWnt9a in E5 (HH27) chick livers. Infectionwith RCAS-H1Wnt9a314 reduced endogenous
Wnt9amRNA compared to the control. (F–H) Effect of Wnt9a silencing on proliferation and histogenesis in E5 (HH26) chick livers. BrdU labeling and the ﬂuorescent detection were
performed. RCAS-Wnt9a314 reduced the number of mitotic cells and induced hepatocellular cord hypoplasia (G) compared to the control (F). Co-infection of RCAS-Wnt9a mut with
RCAS-Wnt9a314 rescued the phenotype induced by RCAS-Wnt9a314 (H). (F′–H′) DAPI staining of panels F–H, respectively. (C–E) EnvmRNA distribution on sections adjacent to panels
F, D, and H, respectively. In all, 40–50% of the cells were infected with the viral vectors. (I) Mitotic index of hepatic epithelial cells in livers with RCAS(A)-GFP (white), with RCAS(A)-
Wnt9a314 (black), or with RCAS(A)-Wnt9a314 and RCAS(B)-Wnt9a mut (gray). The mean mitotic indices were 34.5%, 28.4%, and 35.6%, respectively. RCAS(A)-Wnt9a314 reduced the
mitotic index compared to the control (Pb0.03). Co-infection recovered the mean to that of the control (Pb0.02). Bars, 0.5 mm.
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to the control (Fig. 5G). These results indicate that Wnt9a is required
for normal morphogenesis of hepatocellular cords and sinusoidal
walls (or normal hepatic histogenesis) at later stages. To determinewhether Wnt9a is involved in the maintenance of liver cells, we
assessed apoptosis in virally infected livers using TUNEL. RCAS-
Wnt9a314 increased ectopic apoptosis in the infected liver compared
to the control (Figs. 5J, I). Surprisingly, many TUNEL-positive cells
Fig. 5. Effect ofWnt9a silencingonE15 (HH41) chick liver. (A)Gross anatomyof E15 (HH41)
livers infected with either RCAS(A)-Cont314 (left) or RCAS(A)-Wnt9a314 (right). RCAS(A)-
Wnt9a314 reduced the size of the liver. Bars, 2 mm. (B) Wet weights of E15 (HH41) livers
with either RCAS(A)-Cont314 (white) or RCAS(A)-Wnt9a314 (black). RCAS(A)-Wnt9a314
reduced themeanweight of the liver compared to the control (Pb0.006).N, the number of
embryos sampled. (C, D) Env mRNA distribution in liver sections from either RCAS(A)-
Cont314 (C) or RCAS(A)-Wnt9a314 infected embryos (D). The livers from both treatment
groups showed comparable levels of infection. (E, F) In situ hybridization with a Wnt9a
probe on liver sections of embryos infected with either RCAS(A)-Cont314 (E) or RCAS(A)-
Wnt9a314 (F). RCAS(A)-Wnt9a314 mostly silenced endogenous expression ofWnt9a in the
liver (F) compared to the control (E). (G, H) H&E stained liver sections from embryos
infected with either Cont314 (G) or RCAS(A)-Wnt9a314 (H). RCAS(A)-Wnt9a314 caused
hypoplasia of hepatocellular cords in the liver, which was not evident in the control.
Asterisks in panel H show dilation of sinusoidal spaces caused by RCAS(A)-Wnt9a314.
Arrowheads indicate hepatocellular cords. (I, J) TUNEL assay of liver sections from embryos
infected with either Cont314 (I) or RCAS(A)-Wnt9a314 (J). RCAS(A)-Wnt9a314 caused
increased ectopic apoptosis in infected liver compared to the control. Arrowheads indicate
TUNEL-labeled cells in the sinusoidal wall. (K, L) PAS staining of liver sections of embryos
infected with either RCAS(A)-Cont314 (K) or RCAS(A)-Wnt9a314 (L). RCAS(A)-Wnt9a314
clearly reduced the staining intensity in the liver compared to thecontrol. Bars,1mm(C,D).
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RCAS-Wnt9a314l infected livers (Fig. 5J), whereas few TUNEL-positive
cells were present in the sinusoidal walls to the control (Fig. 5I). At E5
(HH27), only a few TUNEL-positive cells were present in the
sinusoidal walls of RCAS-Wnt9a314-infected livers (data not shown).
These results indicate that Wnt9a is required for the survival of
sinusoidal cells but not of hepatoblasts or hepatocytes at E15. To
conﬁrm the results of the RNAi experiment using RCAS-shRNA, we
used another knockdown vector, RCAS(BP)A-Wnt9a556, that contains
a different candidate short hairpin sequence, Wnt9a556 (Supplemen-
tary Fig. 3A). RCAS(BP)A-Wnt9a556 also decreased the size and weight
of the liver compared to the control (Supplementary Figs. 4B, C).
These observations are consistent with those using RCAS(BP)A-
Wnt9aΔ288 (Supplementary Figs. 2B, C).
Overexpression of Dkk1, a Wnt antagonist, inhibits glycogen
accumulation (Suksaweang et al., 2004). We, therefore, assessed
glycogen accumulation in virally infected hepatocytes at E15, a stage
at which it is normally detectable. PAS staining showed that glycogen
accumulation was greatly reduced in infected livers (Figs. 5K, L),
indicating Wnt9a is required for glycogen accumulation.
Wnt9a is involved in the regulation of glycogen metabolic enzymes
The decreased glycogen accumulation caused by the Wnt9a
knockdown suggests that Wnt9a might be involved in the
transcriptional regulation of genes encoding glycogen and glucose
metabolic enzymes. Prior to analyzing the effect of Wnt9a silencing,
we conﬁrmed the expression of such genes during chick liver
development. At E10 and E15, when glycogen accumulation is
normally observed, glycogen synthase (Gys, a glycogen synthesis
enzyme), and glycogen phosphorylase (a glycogen degradation
enzyme), glucose-6-phosphatase (G6Pase, an enzyme for the ﬁnal
step of the glycogen degradation pathway), and phosphoenolpyru-
vate carboxykinase (PEPCK, a glucose synthesis enzyme) are
expressed (Supplementary Fig. 5). Thus, at E10 and E15, the en-
zymes for glycogen and glucose metabolism are present in the
developing chick liver.
To determine whether Wnt9a is involved in the transcriptional
regulation of these genes, we investigated their expression levels in
Wnt9a-knockdown livers by semi-quantitative RT-PCR. The silencing
ofWnt9a by RCAS(A)Wnt9a314 did not affect the level of expression of
glycogen phosphorylase, but appeared to down-regulate Gys and to up-
regulate G6Pase (Supplementary Fig. 6). We performed quantitative
real-time RT-PCR to conﬁrm these observations. Wnt9a silencing
induced a 6.5-fold increase in the G6Pase expression level, and a 0.5-
fold decrease in the Gys expression level (Supplementary Fig. 6B).
These data indicate that in the hepatocytes of the normal developing
chick liver, Wnt9a negatively regulates G6Pase transcription and
positively regulates Gys.
Wnt9a is essential for β-catenin signaling activation in the embryonic
chick liver
β-catenin, a central component of the canonical Wnt pathway, is
expressed in and crucial for hepatic proliferation in mouse and chick
embryos (Hussain et al., 2004; Suksaweang et al., 2004). Wnt9a
activates Wnt/β-catenin signaling in the developing limb and heart
(Guo et al., 2004; Person et al., 2005; Spater et al., 2006), suggesting
that Wnt9a might also regulate β-catenin signaling in the developing
chick liver.
To assess the role ofWnt9a inWnt/β-catenin signaling during liver
development, we measured the relative ratio of β-catenin in nuclear
lysates of chick livers at different developmental stages (E4–E10).
Canonical Wnt signaling eventually stabilizes the β-catenin protein
(Logan and Nusse, 2004); therefore, the nuclear β-catenin ratio
indicates Wnt/β-catenin signaling activity. The ratio peaked at E4
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was maintained thereafter (Fig. 6A). This temporal pattern resembles
that of Wnt9a transcription (Fig. 1P).
Next, to determine whether Wnt9a was sufﬁcient to activate β-
catenin signaling in the liver, we performed an immunohistochem-
ical analysis of β-catenin localization in livers infected with RCAS-
Wnt9a. In livers overexpressing Wnt9a at E15 (HH41), strong β-catenin staining was evident in the cell membranes and cytoplasm
(Fig. 3H) compared to the control (Fig. 3G). We used a TOPﬂash β-
catenin reporter system to investigate whether Wnt9a mediated an
increase in hepatocyte/hepatoblast proliferation was due to β-
catenin activation (Liu et al., 2003; Nakamura et al., 2003; van de
Wetering et al., 1997). Transfecting RCAS-Wnt9a into the liver cells
induced a 3.4-fold activation of the TOPﬂash reporter compared to
the negative control, RCAS-GFP (Fig. 6C). Similar activation was
mediated by transfecting RCAS-mWnt3a, the positive control (Fig.
6C), indicating that Wnt9a was sufﬁcient to activate β-catenin
signaling in the developing chick liver.
Finally, to ascertain whether Wnt9a was required for Wnt/β-
catenin signaling, we determined the nuclear β-catenin ratio in RCAS
(BP)A-Wnt9a314 infected livers. At E5 (HH27), the knockdown of
Wnt9a caused a 50% reduction in the ratio in infected livers
compared to control (Fig. 6B). This observation suggests that Wnt9a
is required for β-catenin activation and for the Wnt/β-catenin
signaling machinery at the growing stages of chick liver develop-
ment. We obtained the same results with RCAS(BP)A-Wnt9aΔ288
(Supplementary Figs. 2D–F).
Overall, these experiments indicate that Wnt9a/β-catenin signal-
ing regulates both morphogenesis of chick hepatocellular cords and
hepatoblast/hepatocyte proliferation.
Wnt9a signaling components in the developing chick liver
Wg/Wnts activate intracellular pathways by binding to receptors
of the Frizzled (Fzd) family (Wodarz and Nusse, 1998). To identify
the Frizzled(s) mediating Wnt9a signaling from sinusoidal cells, we
examined expression patterns of Frizzled (Fzd1-10) in chick livers at
HH26 (E4.75). Fzd1, 7, and 9 were strongly expressed in the hepatic
epithelium (Figs. 7A, C–E, and G, H); Fzd4 was expressed weakly
in the hepatic epithelium but intensely in the mesothelial layer
(Figs. 7B, F).
We also analyzed the expression patterns of Lef-1, Tcf-1, Tcf-3,
Tcf-4, nuclear components of Wnt pathways, at HH22 (E3.5). Tcf-1
was not detected in the liver (data not shown). Both Lef-1 and Tcf-
4 were expressed in the hepatic epithelium and weakly expressed
in the mesothelial layer (Figs. 7I, K). Tcf-3 was weakly expressed in
the hepatic epithelium, but more intensely in the mesothelial layer
than Tcf-4 and Lef-1 (Fig. 7J). β-catenin was ubiquitously expressed
in the liver at this stage (Fig. 7L). These data suggest that Fzd1, 4,
7, and 9 might transmit Wnt9a signals and regulate the transcrip-
tional activities of Tcf-3, 4 and Lef-1 in chick hepatic epithelial
cells.
To test for interactions between WNT9A and FZD1, 4, 7, and 9, we
performed a co-immunoprecipitation assay (Kubo et al., 2003). A
vector expressing chicken Wnt9a fused to the Fc region of human
IgG (WNT9A-Fc) was co-transfected with vectors expressing myc-
tagged FZD-CRDs (derived from chicken Fzd1, mouse Fzd4, mouse
Fzd7, and human Fzd9) into COS7 cells. Then, WNT9A-Fc in theFig. 6. Wnt9a controls β-catenin signaling in the developing chick liver. (A) Temporal
pattern of nuclear β-catenin in livers at different stages. Top row, Western blot of β-
catenin and laminin A/C in liver nuclear lysates from E4 (HH24) to E10 (HH36). Bottom
row, the relative ratios of nuclear β-catenin to nuclear laminin A/C at E4 (HH24) to E10
(HH36). The highest ratio was present at E4 (HH24), and gradually reduced thereafter as
the liver developed. (B) Effect of Wnt9a silencing on the amount of nuclear β-catenin in
the liver. Top row, aWestern blot of β-catenin and laminin A/C in liver nuclear lysates of
E5 (HH27) embryos infected with either RCAS(A)-Cont314 or RCAS(A)-Wnt9a314. Bottom
row charts the relative ratios of nuclear β-catenin to nuclear laminin A/C in the E5
(HH27) livers. RCAS(A)-Wnt9a314 reduced the ratio (black) compared to the control
(white). (C) TOPﬂash reporter assay of primary cell cultures from E6 (HH29) chick livers.
A reporter plasmid (TOPﬂash) was co-transfected with an effector plasmid (RCAS-GFP,
RCAS-cWnt9a, or RCAS-mWnt3a) into E6 (HH29) chick liver cells. mWnt3a and cWnt9a
increased luciferase activity compared to the control. All experiments were performed
in triplicate (A–C).
Fig. 7. Expression of Wnt signaling components and binding of Frizzled proteins to Wnt9a. (A–D) mRNA distributions of Frizzled1 (A), Frizzled4 (B), Frizzled7 (C), and Frizzled9 (D) in
transverse sections of HH26 (E4.75) chick liver. (E–H) Higher magniﬁcation of panels A–D. Frizzled1 (E), Frizzled7 (G), and Frizzled9 (H) were expressed in the hepatic epithelium.
Frizzled4 was mainly detected in the mesothelium (F). Black, red, and yellow arrowheads indicate hepatic epithelium, sinusoidal wall, and mesothelium, respectively. (I, J) mRNA
distributions of Lef-1 (I), Tcf-3 (J), Tcf-4 (K), and β-catenin (L) in HH26 liver sections. Lef-1, Tcf-3, Tcf-4, and β-catenin were expressed. Bars, 0.1 mm. (M) Binding assay of Fzd-CRD
proteins and Wnt9a. Each of the myc-tagged Fzd-CRDs was co-transfected with Fc-tagged Wnt9a or Fc-tagged GFP as the negative control, and immunoprecipitated using ProteinA
beads. Fzd-CRD co-immunoprecipitation was detected using an anti-myc antibody on a Western blot. Fzd4-CRD, Fzd7-CRD, and Fzd9-CRD co-immunoprecipitated with Wnt9a. The
binding of Fzd4-CRDwas obviously stronger than that of the others. Top row, aWestern blot using an anti-myc antibody and a 5% input of each sample. Second row, aWestern blot for
immunoprecipitated samples using an anti-Fc antibody: left and right asterisks indicate Fc-tagged Wnt9a and Fc-tagged GFP, respectively. Third row, a Western blot for
immunoprecipitated samples using an anti-myc antibody. Arrow, Fzd-CRD bands. Three independent replicates of this experiment were performed.
243K. Matsumoto et al. / Developmental Biology 319 (2008) 234–247lysate was precipitated using ProteinA beads. As a control, GFP-Fc
was co-transfected. FZD4-CRD-myc, FZD7-CRD-myc, and FZD9-CRD-
myc co-immunoprecipitated with WNT9A-Fc. FZD4-CRD-mycshowed greater co-immunoprecipitation than the other proteins
(Fig. 7M). Overall, this experiment suggests that Frizzled 4, 7, and 9
might transmit Wnt9a signals in chick hepatic epithelium.
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The endothelial cells surrounding the liver bud, or the sinusoidal
endothelium derived from them, is essential for the morphogenesis of
the hepatic epithelium (including the liver bud). To date, however, the
factor(s) that promotes the morphogenesis of the hepatic epithelium
has not been identiﬁed. Here, we provide the ﬁrst demonstration that
Wnt9a is one of the hepatic epithelium-morphogenetic factors, derived
from sinusoidal endothelium, in the developing chick liver. We
previously showed that Neurturin is speciﬁcally expressed in the
endotheliumof theductus venosus and that it acts as a chemoattractant
during earlymorphogenetic processes in the liver bud, in particular, for
the extensions of the liver bud around the ductus venosus before HH17
(E2.5) (Tatsumi et al., 2007). In contrast,Wnt9a is speciﬁcally expressed
in sinusoidal walls during later morphogenetic process, such as
migration of hepatoblasts into the STM and their subsequent prolifera-
tion after HH17 (E2.5). Wnt9a is sufﬁcient for and essential to
hepatoblasts/hepatocytes proliferation and for the morphogenesis of
hepatocellular cords. Our results here indicate that Wnt9a is mainly
involved in later developmental processes, and not the early processes
(the extensions of the liver bud around the ductus venosus beforeHH17
(E2.5)), in the chick liver. The later morphogenetic processes in the
hepatic epithelium are conserved in vertebrates. Therefore, a Wnt
corresponding to chickWnt9amight be expressed in hepatic sinusoidal
walls andplay the same role in the developing liver of other vertebrates.
Itwill be important to identify thisWnt inmouse andhumanbecause of
its potential for application to regenerative medicine.
In addition, the onset of Wnt9a expression in the sinusoidal wall
appeared to be the same as that of the epithelial-to-mesenchymal
transition (EMT) (Fig. 1). Therefore, we were unable to determine the
relationship of cause and effect between onset of Wnt9a expression
and EMT. One possible interpretation is that another unknown cue
simultaneously induces both of them. We cannot discount the
possibility that Wnt9a is involved in EMT progression. However, we
were unable to demonstrate such a function by Wnt9a, because it
proved difﬁcult to achieve a sufﬁcient infection of the hepatic
mesoderm by RCAS-WNt9a314 until the onset of EMT. Technical
improvements will undoubtedly provide deﬁnitive information on the
validity of this model.
Wnt9a is essential for the proliferation of hepatic epithelium
In mouse embryonic liver, maintenance of hepatoblast prolifera-
tion after E12.5–13.5 depends on hepatocyte growth factor (HGF)
expressed by the STM (Schmidt et al., 1995; Uehara et al., 1995).
Hepatoblast proliferation before E14 (HH40) appears to depend on an
alternative signaling pathway to the HGF/c-met pathway: it was found
that the livers of HGF-null embryos do not show a reduction in size
prior to E13.5 (Uehara et al., 1995). β-Catenin shows peak activity in
mouse embryonic hepatoblasts during early liver development (E10–
E12) and is required for hepatoblast proliferation during this period
(Micsenyi et al., 2004; Monga et al., 2003), suggesting that the
alternative pathway involves β-catenin signaling. However, it is
uncertain which ligand is responsible for β-catenin activation in
hepatoblasts because β-catenin binds to the intracellular domain of c-
Met and is activated by HGF (Monga et al., 2002). The liver hypoplasia
that results after enforced expression of Dkk-1 or of the dominant-
negative form of Lef1 suggests that Wnt/β-catenin signaling is
important for the proliferation and morphogenesis of hepatic
epithelium (Suksaweang et al., 2004). However, the identity of the
Wnt ligand that is required for this crucial phase of proliferation and
morphogenesis is unknown. Here, we have demonstrated that Wnt9a
is required for chick hepatoblast proliferation and for β-catenin
activation in the hepatoblasts (Figs. 4 and 6). These results support the
hypothesis that proliferation of mouse hepatoblasts prior to E14might
depend on a Wnt ligand.In the developing chick liver, Wnt9a overexpression induced
hyperproliferation of hepatoblasts and hepatocytes, and, secondarily,
caused stenosis of the sinusoidal system (Fig. 3). This suggests that the
scattered expressionofWnt9a in the normal sinusoidalwall is important
for theproperhistogenesis of the embryonic liver.Wehavenot beenable
to identify any relationship between the expression of Wnt9a and
morphological features of the hepatic epithelia, such as new branch
formation from thepreexisting hepatocellular cords. Itwill be important
to determine whether such a relationship exists in order to better
understand the mechanism of histogenesis in the developing liver.
We performed two independent experiments to suppress endo-
genous Wnt9a expression in vivo (Fig. 5 and Supplementary Fig. 4).
One approach was to use RNA interference by shRNAs to suppress
Wnt9a expression. Generally, when exploiting the RNA interference
approach to silence a target mRNA, it is essential to verify that the
same result can be achieved using two different shRNAs directed
against distinct sites in the target mRNA, and, if possible, to show that
the phenotype caused by an shRNA can be rescued by an shRNA-
resistant target RNA. In the experiments described here, suppression
of hepatoblast proliferationwas induced by two independent shRNAs,
and the inhibitory potential ofWnt9a314 was rescued by co-expression
ofWnt9amut (Fig. 4I and Supplemental Fig. 4A). Therefore, the results
of our Wnt9a silencing experiments fulﬁll the desired criteria and are
therefore credible. Our second strategy was to enforce expression of a
dominant-negative form of Wnt9a (Person et al., 2005), and we
obtained the same results as in the RNA interference experiments
(Supplemental Fig. 2). This outcome also provides credence to the
results of our gene silencing experiment.
In the Wnt9a silencing experiments, we did not observe any
phenotypes at HH17–18 (E2.5) when the hepatoblasts began to
migrate from the liver bud into the STM. This does not necessarily
mean thatWnt9a does not function during this period. One possibility
is that the viral vector required more than 24 h for sufﬁcient
expression of external genes, and the shRNAs were expressed at too
low a level at HH17–18 (E2.5) using our experimental procedure. The
enforced expression of the dominant-negative form of Lef1 in HH13
(E2) hepatic endoderm induced a severe morphological anomaly of
the liver bud at HH17 (E2.5) (data not shown), suggesting that aWnt is
involved. It may be necessary to examine the effect of Wnt9a silencing
on the liver development following effective infection by virus vectors
of the target tissue (sinusoidal cells) at earlier developmental stages.
In the developing chick liver, hepatoblast proliferation has two
phases: a ubiquitous proliferation phase until E4 and an additive
proliferation phase in the peripheral growth zone, which gradually
becomesmore important after E4 and is dominant after E6 (Nakayama
et al., 2006; Suksaweang et al., 2004). The later additive proliferation
phase depends on β-catenin/Wnt signaling (Suksaweang et al., 2004).
Here, we found that Wnt9a silencing tends to suppress hepatocellular
cord formation centrally but not in peripheral regions, and that it
reduces activated β-catenin in the affected liver (Fig. 6B). These data
strongly suggest that the central proliferation is regulated by the
Wnt9a/β-catenin pathway, and that peripheral proliferation may be
compensated by other Wnts. It is known that Wnt3a, and 8b are
peripherally expressed in the chick embryonic liver (Suksaweang et
al., 2004). Therefore, in the peripheral region, these two Wnts might
activate β-catenin signaling to promote hepatoblast proliferation
cooperatively withWnt9a. The liver size reduction caused by enforced
expression of the dominant-negative form of Wnt9a was more severe
than that caused by the silencing of expression by shRNAs. These data
also support the possibility that other Wnts may also have a role in
hepatoblast proliferation.
Wnt9a is involved in glycogen accumulation
Hepatoblasts are bipotential progenitor cells that give rise to
hepatocytes and biliary epithelial cells. Here, we found that in
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Wnt9a silencing inhibited glycogen accumulation (a metabolic
function characteristic of mature hepatocytes) in the hepatocytes of
the affected liver (Fig. 5). It was previously reported that β-catenin
signaling is also involved in glycogen accumulation in the developing
chick liver (Suksaweang et al., 2004). The information presented here
and from this earlier study therefore indicates that Wnt9a is required
for glycogen accumulation in hepatocytes.
How does Wnt9a regulate glycogen accumulation in hepato-
cytes? To address this question, we investigated the expression
levels of three glycogen metabolic enzymes, glycogen phosphorylase,
G6Pase, and Gys. In Wnt9a silenced livers, G6Pase was increased and
Gys decreased compared to the control (Supplementary Fig. 6).
These observations suggest that in normal developing hepatocytes,
Wnt9a is required for suppressing G6Pase expression at a level
appropriate for prevention of excess glycogen degradation, and for
maintaining Gys expression to promote glycogen synthesis. This
model receives partial support from evidence that inhibition of GSK-
3 selectively reduces G6Pase expression in the adult hepatoma
(Lochhead et al., 2001).
Alternatively, Wnt9a may indirectly control glycogen accumula-
tion in hepatocytes via sinusoidal defects: Wnt9a silencing induced
ectopic apoptosis in non-parenchymal cells (Fig. 5J); in normal
development, Wnt9a is required for maintenance and functional
differentiation of sinusoidal cells (fenestration formation). In contrast,
reduced Wnt9a expression causes a fenestration defect in the
sinusoidal endothelium, resulting in the suppression of diffusion of
glucose-containing blood plasma from sinusoids to the space of Disse.
To determine whether the latter is involved, it will be necessary to
investigate the effect of Wnt9a silencing on fenestration formation in
the sinusoidal endothelium of affected livers.
Function of Wnt/β-catenin signaling and its signaling components in
liver development
Wnt/β-catenin signaling is known to play multiple roles in distinct
steps during development of the liver. Wnt2bb, which is expressed in
the lateral plate mesoderm and mediates Wnt/β-catenin signaling, is
initially required for liver speciﬁcation in zebraﬁsh (Ober et al., 2006).
To date, it is not clear whether Wnt/β-catenin is required for liver
speciﬁcation signaling in the mammal and chick. Wnt9a cannot be
involved in liver speciﬁcation because its expression only initiates at
HH17 (E2.5) when hepatic speciﬁcation has already been completed.
Enforced expression of the dominant-negative form of Lef1 to block
Wnt/β-catenin signaling in hepatic endoderm at HH13 (E2) resulted in
morphological defects in liver buds (data not shown). This suggests
that Wnt/β-catenin signaling is important for liver bud morphogen-
esis after HH13 (E2).
In vertebrate genomes,19members of theWnt protein family have
been identiﬁed and found to play divergent roles in embryogenesis.
Wnt stimuli evoke the canonical (Wnt/β-catenin pathway) or non-
canonical pathways (Wnt/Ca2+ pathway or Wnt/Planar Cell Polarity
(PLP) pathway) in a ligand-dependent manner. Many Wnts can
activate the canonical pathway: Wnt5a and Wnt11 activate the Wnt/
Ca2+ pathway (Kuhl et al., 2000; Slusarski et al., 1997) and, Wnt11 in
gastrulation movement activates the Wnt/PCP pathway (Heisenberg
et al., 2000; Tada and Smith, 2000). Which pathway might be used
when Wnt9a promotes hepatic proliferation? Wnt9a silencing
reduced the amount of nuclear β-catenin in liver cells (Fig. 6B) and
promoted luciferase activity of the TOPﬂash reporter in vitro (Fig. 6C),
suggesting that Wnt9a is involved in the activation of the β-catenin
pathway in hepatoblasts. Does Wnt9a-mediated hepatoblast prolif-
eration depend only on the β-catenin pathway? This is probably the
case and it is unlikely that the non-canonical pathway is involved in
this phenomenon. Enforced expression of the dominant-negative
form of Lef1, a transcription factor of the Wnt/β-catenin pathway,induces suppression of hepatoblast proliferation in a similar fashion to
Wn9a silencing in the chick liver (Suksaweang et al., 2004).
The possible role of Wnt9a in mouse liver development
During mouse liver development, β-catenin signaling is twice
involved in the proliferation of hepatic epithelium: ﬁrst, for prenatal
proliferation of hepatoblasts during E10–E14 (Micsenyi et al., 2004);
second, for postnatal proliferation of hepatocytes within the ﬁrst
month after birth (Apte et al., 2007). Is Wnt9a involved in the
proliferation of the hepatic epithelium in the developing mouse liver
as is the case in the chick embryo? We found that Wnt9a was not
expressed in E10–E12 mouse embryonic livers, suggesting thatWnt9a
is not involved in prenatal hepatoblast proliferation (data not shown).
In the mouse embryonic liver, Wnt ligand(s) other than Wnt9a might
be expressed in endothelial cells and involved in embryonic liver
growth via β-catenin signaling. However, Wnt9a is expressed in the
adult mouse liver (Zeng et al., 2007). Therefore, Wnt9a might have a
function in postnatal growth or regeneration of mouse liver. To more
fully understand the regulatory mechanisms for hepatoblast and
hepatocyte proliferation, it will be important to identify theWnts that
are expressed in endothelial cells and that are involved in the
proliferation of hepatic epithelium in the mouse and other vertebrate
embryos.
Wnt9a activates the β-catenin pathway in hepatoblasts via Fzd7 and
Fzd9
Wnt stimuli are transmitted by Frizzled family proteins, a
transmembrane receptor family for Wnts, and activate intracellular
signaling cascades such as β-catenin signaling. Here, we found that of
10 members of the Fzd family, Fzd1, 4, 7, and 9 were expressed in
hepatoblasts and that Fzd4 was expressed in the hepatic mesothelium
(Figs. 7A–H). Co-immunoprecipitation assays showed that Wnt9a was
selectively bound to Frz4, Fzd7, and Frz9 (Fig. 7M). These results
indicate that Fzd7/9 and Fzd4 are the major receptors for Wnt9a in
hepatoblasts and hepatic mesothelium, respectively. Fzd7/9, and Fzd4
can transduceβ-catenin signalingboth in vivo and in vitro (Karasawa et
al., 2002;Merle et al., 2004;Merle et al., 2005;Mikels andNusse, 2006;
Sumanas et al., 2000). In particular, Fzd7 is expressed in hepatocellular
carcinomas and is associated with Wnt/β-catenin pathway activation
(Merle et al., 2005). A full understanding of the mechanisms of the
interaction between the hepatic epithelium and hepatic endothelium
will require identiﬁcation of the true receptor of Wnt9a.
Conclusion
In this report, we have demonstrated that Wnt9a is expressed in
the sinusoidal wall and is essential for the normal proliferation of
hepatoblasts and hepatocytes in the developing liver. These ﬁndings
provide the ﬁrst genetic evidence that interactions between the
hepatic epithelium and sinusoidal cells are mediated by Wnt9a/
Frizzled signaling, and that the signaling regulates proliferation,
morphogenesis and differentiation of hepatic parenchyma in the
developing chick liver. These observations should contribute to the
development of a culture system that is suitable for analyzing the
mechanisms of proliferation and differentiation of hepatoblasts prior
to E14. Moreover, the data we present here should also be useful for
developing procedures to expand the number of hepatoblasts that can
be induced from somatic or embryonic stem cells for use in clinical
and therapeutic applications.
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Appendix A. Supplementary methods
Double-colored in situ hybridization
Double-colored in situ hybridization was performed as described
previously (Wilkinson, 1993) with minor modiﬁcations. For double-
colored in situ hybridization, the ﬁrst color was detected using INT/
BCIP (Roche) or Vector Red (Vector); the staining reaction was halted
using two washes with PBS containing 0.01% Tween 20/PBT for
10 min, and the sections were ﬁxed in 4% paraformaldehyde/PBS for
1 h at 4 °C. The sections were washed (2×30 min) with Tris–HCl
buffered saline containing 0.05% Tween 20 (TBST). They were then
incubated overnight at 4 °C in alkaline phosphatase-conjugated anti-
digoxigenin or ﬂuoroscein-conjugated antibodies (diluted 1:1000
with TBST, Roche). The sections were washed (3×20 min) with TBST
containing 2 mmol/l levamisole and incubated for 5 min in NTMT
(100 mmol/l NaCl, 100 mmol/l Tris–HCl (pH9.5), 50 mmol/l MgCl2,
0.1% Tween 20) containing 2 mmol/l levamisole. The second color
reaction was detected with NBT/BCIP (Roche) in NTMT.
Immunohistochemistry after in situ hybridization
After in situ hybridization, the sections were stained using Vector
Red (Vector). The color reaction was stopped by washing with PBT
(3×10 min). The sections were then ﬁxed in 4% paraformaldehyde/
PBS for 1 h at 4 °C, and washed with PBT (2×30 min). They were
next washed twice with TBST and incubated overnight at 4 °C with
rabbit anti-DESMIN (1:20, D8281, Sigma). After incubation, the
sections were washed three times with TBST. Primary antibodies
were detected using AlexaFluor 488 goat anti-rabbit IgG (1:300,
Molecular Probes).
Knockdown of gene expression
We used a small hairpin RNA (shRNA) expressing vector
(pEGFPH1) based on pEGFPN-1, which transcribes an EGFP mRNA
under a CMV promoter and can transcribe an shRNA composed of
two complements of 19 nt sequences separated by a 4 nt spacer,
under a human H1 promoter. The wave tool of BLOCK-iT™ RNAi
Designer (https://rnaidesigner.invitrogen.com/rnaiexpress; Invitro-
gen) was used to search for appropriate 19 nt sequences from
cWnt9a cDNA and selected four candidates. These candidates
satisﬁed the criteria that each sequence should be immediately
downstream of an AA, should start with a GG, and should have about
50% GC content. The four target sequences have no homology with
known sequences in the database. The oligonucleotide sequences
used are listed in Table 2. Pairs of Top and Bottom strand oligos for
each shRNA template were annealed, each double-strand oligo wasinserted into the BglII–HindIII site of the pEGFPH1 vector. For gene
silencing assay, 293T cells were co-transfected with plasmids
expressing shRNA and EGFP (pEGFPH1-shRNA) or a GFP-tagged
chick Wnt9a expression plasmid (pEGFP-cWnt9a or pEGFP-cWnt9a
mutant) using Polyfect (Qiagen). Two days after transfection, cell
lysates were analyzed using a Western blotting technique. To detect
GFP, we used a rabbit anti-GFP (1:1000, Code No.598, MBL), followed
by HRP-conjugated goat anti-rabbit IgG (GE Healthcare). After
evaluating siRNA efﬁciency for gene silencing, the region from the
human H1 promoter to the hairpin sequence in pEGFPH1-shRNA was
ampliﬁed by PCR using the primers 5′-ACGCGGAACTCCATATATGG-3′
and 5′-CTATCGATAACCGTATTACCGCCATGC-3′. The ClaI-digested PCR
product was inserted into ClaI site of RCAS(BP)A (Hughes et al.,
1987). Plasmids expressing mutant forms of cWnt9a were con-
structed using pEGFPN-1 (Clontech) and pSlax12-cWnt9a (kindly
provided by Dr. C. Hartmann; (Hartmann and Tabin, 2001). To
construct pEGFP-Wnt9a, the partial cDNA of chick Wnt9a (1–600 bp;
1–200 amino acids) was ampliﬁed by PCR using the primers 5′-
GGAAGCTTGGACGTGCAGCCGACCAC-3′ and 5′-TTGAGGATCCTT-
CATGCCCACAAGG-3′, and fused to EGFP cDNA. The pEGFP-Wnt9a
and pSlax-cWnt9a mutants were generated using a PCR-based
mutagenesis method. Brieﬂy, two rounds PCR ampliﬁcation were
used to substitute 6 nucleotides. The ﬁrst PCR was performed with
the primers 5′-CTGCTGAAGAGGGGGTTTAAGGAGACGGCC-3′ and 5′-
CCGTCTCCTTAAACCCCCTCTTCAGCAGAC-3′ using the following pro-
gram: 95 °C, 30 s; 55 °C, 1 min; 68 °C, 5 min 30 s (18 cycles). pEGFP-
Wnt9a or pSlax12-Wnt9a were used as the templates. The PCR
products were digested with DpnI at 37 °C for 2 h. After verifying the
presence of mutations within the products, the second PCR was
performed with the primers 5′-ACCTCTCTTCAGCAGACTGGCCCGG-
TAGCG-3′ and 5′-TACCGGGCCAGTCTGCTGAAGAGAGGTTTC-3′ using
the same program. The ﬁrst PCR products were used as the
templates. After verifying the sequence, the pSlax12-Wnt9a mutant
was digested with ClaI and inserted into ClaI-digested RCAS(BP)B
(Hughes et al., 1987).
Appendix B. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.ydbio.2008.04.021.
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